Public Accounts committee  In every market where we were working with procurement to sign these contracts, they would have had access.

Public Accounts committee  I'm not sure, but I can get back to the clerk on this.

Public Accounts committee  I'm not familiar with all of those instances, but I do know there have been a couple of leaks. They were taken down right away.

Public Accounts committee  I'm not exactly sure if we know who leaked the information, but in these cases, Pfizer never voluntarily provided an unredacted contract.

Public Accounts committee  I can't answer that. I'm sorry.

Public Accounts committee  I don't think in any of these cases.... I'll speak on Pfizer's behalf that we never implied we would divest if a contract was leaked.

Public Accounts committee  These are two-way contracts signed by both us and the department of procurement. It is our intent that these are always confidential, and we retain confidentiality throughout.

Public Accounts committee  Thank you for the question. Pfizer has not.

Public Accounts committee  Similarly, Pfizer's position is to not provide unredacted contracts, and we have not done so across the globe.

Public Accounts committee  Good day, Mr. Chair and members of the committee. My name is Najah Sampson. I'm president of Pfizer Canada. Thank you for your invitation to share Pfizer’s perspective on the motion before you. I am here with my colleague Fabien Paquette, our mRNA vaccines and antiviral portfolio lead in Canada, who is joining us remotely.